Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Philipp Harter; Patricia Pautier; Els Van Nieuwenhuysen; Alexander Reuss; Andres Redondo; Kristina Lindemann; Christian Kurzeder; Edgar Petru; Florian Heitz; Jalid Sehouli; Nikolaus Degregorio; Pauline Wimberger; Alexander Burges; Nadin Cron; Jonathan Ledermann; Domenica Lorusso; Xavier Paoletti; Frederik Marme

doi:10.1136/ijgc-2020-001572

Article info

other Versions

You are currently viewing an earlier version of this article (June 30, 2020).
View the most recent version of this article

Clinical trial

Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Authors

Philipp Harter Gynecology and Gynecologic Oncology, AGO & Ev. Kliniken Essen-Mitte, Essen, Germany PubMed articles Google scholar articles
Patricia Pautier GINECO & Gustave Roussy, Villejuif, France PubMed articles Google scholar articles
Els Van Nieuwenhuysen Gynecological Oncology, BGOG & University Hospitals Leuven, Leuven, Belgium PubMed articles Google scholar articles
Alexander Reuss Coordinating Centre for Clinical Trials, AGO & Philipps-University, Marburg, Germany PubMed articles Google scholar articles
Andres Redondo IdiPaz, GEICO & Hospital Universitario La Paz, Madrid, Spain PubMed articles Google scholar articles
Kristina Lindemann NSGO & Oslo University Hospital, Unversity of Oslo, Oslo, Norway PubMed articles Google scholar articles
Christian Kurzeder SAKK & University Hospital of Basel, Basel, Switzerland PubMed articles Google scholar articles
Edgar Petru AGO-Austria & Graz University, Graz, Austria PubMed articles Google scholar articles
Florian Heitz Gynecology and Gynecologic Oncology, AGO & Ev. Kliniken Essen-Mitte, Essen, Germany PubMed articles Google scholar articles
Jalid Sehouli Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, AGO & Charité Berlin, Berlin, Germany PubMed articles Google scholar articles
Nikolaus Degregorio AGO & University Ulm, Ulm, Germany PubMed articles Google scholar articles
Pauline Wimberger Gyncology and Obstetrics, AGO & TU Dresden, Dresden, Germany PubMed articles Google scholar articles
Alexander Burges AGO & LMU Munich, Munchen, Bayern, Germany PubMed articles Google scholar articles
Nadin Cron AGO, Essen, Germany PubMed articles Google scholar articles
Jonathan Ledermann UCL Cancer Institute, University College, London, UK PubMed articles Google scholar articles
Domenica Lorusso Policlinico Gemelli, Rome, Italy PubMed articles Google scholar articles
Xavier Paoletti Institute Curie, Paris, France PubMed articles Google scholar articles
Frederik Marme AGO & University Mannheim, Mannheim, Germany PubMed articles Google scholar articles

Correspondence to Dr Philipp Harter, Gynecology and Gynecologic Oncology, AGO & Ev. Kliniken Essen-Mitte, Essen 45136, Germany; p.harter{at}gmx.de

View Full Text

Citation

Harter P, Pautier P, Van Nieuwenhuysen E, et al

Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

International Journal of Gynecologic Cancer Published Online First: 30 June 2020. doi: 10.1136/ijgc-2020-001572

Publication history

Accepted June 5, 2020
First published June 30, 2020.

Article Versions

You are currently viewing a Previous version of this article (30 June 2020).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password